Pfizer - 51 Year Dividend History | PFE

Historical dividend payout and yield for Pfizer (PFE) since 1974. The current TTM dividend payout for Pfizer (PFE) as of July 08, 2025 is $1.72. The current dividend yield for Pfizer as of July 08, 2025 is 6.81%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $143.499B $63.627B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $732.476B 56.17
Johnson & Johnson (JNJ) United States $373.591B 15.45
AbbVie (ABBV) United States $331.430B 18.27
Novo Nordisk (NVO) Denmark $309.514B 20.51
Novartis AG (NVS) Switzerland $257.969B 14.73
Roche Holding AG (RHHBY) Switzerland $257.158B 0.00
Merck (MRK) United States $203.142B 10.39
Sanofi (SNY) France $118.503B 11.67
Bayer (BAYRY) Germany $30.023B 6.11
Innoviva (INVA) United States $1.187B 12.44